Dissemination patterns in non-gastric MALT lymphoma

Haematologica

Volumn 93, Issue 2, 2008, Pages 201-206

  De Boer, Jan Paul ^a,c   Hiddink, Reinier Frederik ^a   Raderer, Markus ^b   Antonini, Ninja ^a   Aleman, Berthe Mauricia Pauline ^a   Boot, Henk ^a   De Jong, Daphne ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b UNIVERSITY OF VIENNA   (Austria)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Dissemination patterns; Extranodal marginal zone lymphoma; MALT

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE MARROW; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISSEMINATED CANCER; FEMALE; FOLLOW UP; GASTRITIS; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MONOTHERAPY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; PROGNOSIS; RECURRENT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; BONE MARROW NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LUNG NEOPLASMS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 40849116572     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11835     Document Type: Article

References (21)

1. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983;52:1410-6.
2. Isaacson PG, Du MQ. MALT Lymphoma: from morphology to molecules. Nat Rev Cancer 2004;4:644-53.
3. Cavalli F, Isaacson PG, Gascoyne RD, Zucca E. MALT lymphomas. Hematology (Am Soc Hematol Educ Program) 2001;241-58.
4. Bertoni F, Zucca E. State-of-the-art therapeutics: marginal-zone lymphoma. J Clin Oncol 2005; 23:6415-20.
5. Zucca E, Conconi A, Pedrinis E, Cortelazzo S, Motta T, Gospodarowicz MK, et al. Non-gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. International Extranodal Lymphoma Study Group. Blood 2003; 101:2489-95.
6. Dogan A, Du M, Koulis A, Briskin MJ, Isaacson PG. Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue. Am J Pathol 1997;151:1361-9.
7. Briskin M, Winsor-Hines D, Shyjan A, Cochran N, Bloom S, Wilson J, et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol 1997;151:97-110.
8. Krol AD, Hermans J, Kramer MH, Kluin PM, Kluin-Nelemans HC, Blok P, et al. Gastric lymphomas compared with lymph node lymphomas in a population-based registry differ in stage distribution and dissemination patterns but not in patient survival. Cancer 1997;79:390-7.
9. Krol AD, Hermans J, Dawson L, Snijder S, Wijermans PW, Kluin-Nelemans HC, et al. Treatment, patterns of failure, and survival of patients with stage I nodal and extranodal non-Hodgkin's lymphomas, according to data in the population-based registry of the Comprehensive Cancer Centre West. Cancer 1998;83:1612-9.
10. Thieblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, Felman P, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000; 95:802-6.
11. Zinzani PL, Magagnoli M, Galieni P, Martelli M, Poletti V, Zaja F, et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol 1999;17:1254-8.
12. Arcaini L, Burcheri S, Rossi A, Passamonti F, Paulli M, Boveri E, et al. Non-gastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination. Oncologist 2006;11:285-91.
13. Raderer M, Wöhrer S, Streubel B, Troch M, Turetschek K, Jäger U, et al. Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol 2006; 24:3136-41.
14. WHO Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001.
15. Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 2006;107:3034-44.
16. Raderer M, Vorbeck F, Formanek M, Osterreicher C, Valencak J, Penz M, et al. Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma. Br J Cancer 2000;83:454-7.
17. Jäger G, Neumeister P, Brezinschek R, Hinterleitner T, Fiebiger W, Penz M, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol 2002;20:3872-7.
18. Hammel P, Haioun C, Chaumette MT, Gaulard P, Divine M, Reyes F, et al. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol 1995;13:2524-9.
19. Zinzani PL, Stefoni V, Musuraca G, Tani M, Alinari L, Gabriele A, et al. Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer 2004;100:2190-4.
20. Raderer M, Wohrer S, Bartsch R, Prager G, Drach J, Hejna M, et al. Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 2005; 23:8442-6.
21. Conconi A, Martinelli G, Thieblemont C, Ferreri AJ, Devizzi L, Peccatori F, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003;102:2741-5.